Abstract：
OBJECTIVE: To report the long-term anatomical and functional results of macular buckle for Myopic Traction Maculopathy (MTM) in stages 3a, 3b, 4a, and 4b according to the MTM Staging System (MSS).
METHODS: Retrospective observational cohort study involving 55 consecutive patients with MTM in stages 3a, 3b, 4a, and 4b who underwent macular buckle (MB). Postoperative outcomes, including optical coherence tomography (OCT) scans to evaluate the MTM stage and its progression, were evaluated 1-month postoperatively (i.e., \"intermediate follow-up\") and at last follow-up ranging between 6 and 156 months postoperatively (i.e., \"final follow-up\").
RESULTS: Fifty-five eyes affected by MTM who underwent MB were enrolled. The mean preoperative and postoperative axial length was 31.13 ± 2.14 and 29.73 ± 2.16 mm, respectively (p < 0.01), with a mean axial shift of 1.32 ± 0.77 mm. The mean sample best corrected visual acuity (BCVA) at baseline, intermediate, and final follow-ups was 0.87 ± 0.36, 0.73 ± 0.31, 0.41 ± 0.32 logMar, respectively (p < 0.01). Foveal and retinal anatomical improvements were achieved in 50 (91%) and 53 (96.4%) eyes at intermediate follow-up, respectively. In the final follow-up, 54 (98.2%) and 55 (100%) eyes showed foveal and retinal anatomical improvements, respectively.
CONCLUSIONS: MB as a single procedure, when applied to MTM in stages 3a, 3b, 4a, and 4b, leads to significant anatomical and functional improvement. The MTM Staging System allows us to evaluate the best surgical technique and the surgical timing tailored to the different stages to increase the surgery\'s success and lower the complications of each technique.
METHODS: Retrospective observational cohort study involving 55 consecutive patients with MTM in stages 3a, 3b, 4a, and 4b who underwent macular buckle (MB). Postoperative outcomes, including optical coherence tomography (OCT) scans to evaluate the MTM stage and its progression, were evaluated 1-month postoperatively (i.e., \"intermediate follow-up\") and at last follow-up ranging between 6 and 156 months postoperatively (i.e., \"final follow-up\").
RESULTS: Fifty-five eyes affected by MTM who underwent MB were enrolled. The mean preoperative and postoperative axial length was 31.13 ± 2.14 and 29.73 ± 2.16 mm, respectively (p < 0.01), with a mean axial shift of 1.32 ± 0.77 mm. The mean sample best corrected visual acuity (BCVA) at baseline, intermediate, and final follow-ups was 0.87 ± 0.36, 0.73 ± 0.31, 0.41 ± 0.32 logMar, respectively (p < 0.01). Foveal and retinal anatomical improvements were achieved in 50 (91%) and 53 (96.4%) eyes at intermediate follow-up, respectively. In the final follow-up, 54 (98.2%) and 55 (100%) eyes showed foveal and retinal anatomical improvements, respectively.
CONCLUSIONS: MB as a single procedure, when applied to MTM in stages 3a, 3b, 4a, and 4b, leads to significant anatomical and functional improvement. The MTM Staging System allows us to evaluate the best surgical technique and the surgical timing tailored to the different stages to increase the surgery\'s success and lower the complications of each technique.
摘要：
目的：报告3a期近视牵引性黄斑病变（MTM）黄斑扣的长期解剖和功能结果，3b,4a,和4b根据MTM分级系统(MSS)。
方法：回顾性观察性队列研究，包括55名连续的MTM3a期患者，3b,4a,和4b谁接受黄斑扣（MB）。术后结果,包括光学相干断层扫描（OCT）扫描，以评估MTM阶段及其进展，术后1个月进行评估(即，“中间随访”)和术后6至156个月的最后随访(即，“最终随访”)。
结果：纳入55只受MB影响的MTM患者。术前和术后平均眼轴长度分别为31.13±2.14和29.73±2.16mm，分别为(p<0.01)，平均轴向位移为1.32±0.77毫米。基线时的平均样本最佳矫正视力(BCVA)，中间,最终随访为0.87±0.36、0.73±0.31、0.41±0.32logMar，分别(p<0.01)。在中期随访时，50只（91%）和53只（96.4%）眼实现了中心凹和视网膜解剖改善，分别。在最后的后续行动中，54只（98.2%）和55只（100%）的眼睛显示出中央凹和视网膜解剖结构的改善，分别。
结论：MB作为单个程序，当应用于阶段3a中的MTM时，3b,4a,4b,导致显著的解剖和功能改善。MTM分期系统使我们能够评估最佳手术技术和针对不同阶段量身定制的手术时机，以提高手术成功率并降低每种技术的并发症。
方法：回顾性观察性队列研究，包括55名连续的MTM3a期患者，3b,4a,和4b谁接受黄斑扣（MB）。术后结果,包括光学相干断层扫描（OCT）扫描，以评估MTM阶段及其进展，术后1个月进行评估(即，“中间随访”)和术后6至156个月的最后随访(即，“最终随访”)。
结果：纳入55只受MB影响的MTM患者。术前和术后平均眼轴长度分别为31.13±2.14和29.73±2.16mm，分别为(p<0.01)，平均轴向位移为1.32±0.77毫米。基线时的平均样本最佳矫正视力(BCVA)，中间,最终随访为0.87±0.36、0.73±0.31、0.41±0.32logMar，分别(p<0.01)。在中期随访时，50只（91%）和53只（96.4%）眼实现了中心凹和视网膜解剖改善，分别。在最后的后续行动中，54只（98.2%）和55只（100%）的眼睛显示出中央凹和视网膜解剖结构的改善，分别。
结论：MB作为单个程序，当应用于阶段3a中的MTM时，3b,4a,4b,导致显著的解剖和功能改善。MTM分期系统使我们能够评估最佳手术技术和针对不同阶段量身定制的手术时机，以提高手术成功率并降低每种技术的并发症。
